Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tllsh2910 in Multiple System Atrophy
NCT03901638Phase 3Terminated
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tllsh-2910 in multiple system atrophy (MSA), cerebellar ataxia (CA), sponsored by National Taiwan University Hospital. Started Apr 2019; status: terminated.
02
Drugs
Tllsh-2910
03
Conditions
multiple system atrophy (MSA)cerebellar ataxia (CA)
Beyond the preview
Go deeper on NCT03901638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03901638.